BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
C.-L. Lin, J.-H. Kao. Review article: novel therapies for hepatitis B virus cure - advances and perspectivesAlimentary Pharmacology & Therapeutics 2016; 44(3): 213 doi: 10.1111/apt.13694
2
Jiaqian Pan, Shuangmei Tong, Lei Kang, Jing Tang. New anti-hepatitis B virus drugs under development and evaluationCurrent Opinion in Infectious Diseases 2016; 29(6): 632 doi: 10.1097/QCO.0000000000000318
3
Xuefeng Zhang, Jing Wang, Jing Lu, Rongrong Li, Shuli Zhao. Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primatesVirology Journal 2018; 15(1) doi: 10.1186/s12985-018-1026-3
4
Rosario Casillas, David Tabernero, Josep Gregori, Irene Belmonte, Maria Francesca Cortese, Carolina González, Mar Riveiro-Barciela, Rosa Maria López, Josep Quer, Rafael Esteban, Maria Buti, Francisco Rodríguez-Frías. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish populationWorld Journal of Gastroenterology 2018; 24(6): 680-692 doi: 10.3748/wjg.v24.i6.680
5
Chih-Lin Lin, Hung-Chih Yang, Jia-Horng Kao. Hepatitis B virus: new therapeutic perspectivesLiver International 2016; 36: 85 doi: 10.1111/liv.13003
6
Ran Xia, Li-Ping Sun, Gui-Rong Qu. The synthesis of nebularine and its analogs via oxidative desulfuration in aqueous nitric acidPhosphorus, Sulfur, and Silicon and the Related Elements 2017; 192(1): 88 doi: 10.1080/10426507.2016.1225057
7
Vincent Soriano, Pablo Barreiro, Laura Benitez, Jose M. Peña, Carmen de Mendoza. New antivirals for the treatment of chronic hepatitis BExpert Opinion on Investigational Drugs 2017; 26(7): 843 doi: 10.1080/13543784.2017.1333105
8
Yadira Lobaina, Marie-Louise Michel. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trialsVaccine 2017; 35(18): 2308 doi: 10.1016/j.vaccine.2017.03.049